160 related articles for article (PubMed ID: 24524088)
1. Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.
Huber G; Bánki Z; Kunert R; Stoiber H
Biomed Res Int; 2014; 2014():971345. PubMed ID: 24524088
[TBL] [Abstract][Full Text] [Related]
2. Nanocell targeting using engineered bispecific antibodies.
Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
[TBL] [Abstract][Full Text] [Related]
3. Design, production, and characterization of a single-chain variable fragment (ScFv) derived from the prostate specific membrane antigen (PSMA) monoclonal antibody J591.
Parker SA; Diaz IL; Anderson KA; Batt CA
Protein Expr Purif; 2013 Jun; 89(2):136-45. PubMed ID: 23500147
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bovine herpesvirus type 1 neutralization by multimerized single-chain variable antibody fragments regardless of differential glycosylation.
Pasman Y; Nagy E; Kaushik AK
Clin Vaccine Immunol; 2012 Aug; 19(8):1150-7. PubMed ID: 22695166
[TBL] [Abstract][Full Text] [Related]
5. Codon modification for the DNA sequence of a single-chain Fv antibody against clenbuterol and expression in Pichia pastoris.
Dong JX; Xie X; Hu DW; Chen SC; He YS; Beier RC; Shen YD; Sun YM; Xu ZL; Wang H; Yang JY
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3679-89. PubMed ID: 24190495
[TBL] [Abstract][Full Text] [Related]
6. High efficient expression of a functional humanized single-chain variable fragment (scFv) antibody against CD22 in Pichia pastoris.
Zarei N; Vaziri B; Shokrgozar MA; Mahdian R; Fazel R; Khalaj V
Appl Microbiol Biotechnol; 2014 Dec; 98(24):10023-39. PubMed ID: 25239038
[TBL] [Abstract][Full Text] [Related]
7. Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.
Choi BD; Gedeon PC; Kuan CT; Sanchez-Perez L; Archer GE; Bigner DD; Sampson JH
J Immunol Methods; 2013 Sep; 395(1-2):14-20. PubMed ID: 23806556
[TBL] [Abstract][Full Text] [Related]
8. Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in
Xiong C; Mao Y; Wu T; Kang N; Zhao M; Di R; Li X; Ji X; Liu Y
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257416
[TBL] [Abstract][Full Text] [Related]
9. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
Sharma SK; Suresh MR; Wuest FR
Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
[TBL] [Abstract][Full Text] [Related]
10. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
[TBL] [Abstract][Full Text] [Related]
11. Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.
Metz S; Panke C; Haas AK; Schanzer J; Lau W; Croasdale R; Hoffmann E; Schneider B; Auer J; Gassner C; Bossenmaier B; Umana P; Sustmann C; Brinkmann U
Protein Eng Des Sel; 2012 Oct; 25(10):571-80. PubMed ID: 22976197
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma.
Zou J; Chen D; Zong Y; Ye S; Tang J; Meng H; An G; Zhang X; Yang L
Cancer Sci; 2015 May; 106(5):512-21. PubMed ID: 25664501
[TBL] [Abstract][Full Text] [Related]
13. The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
Seifert O; Plappert A; Heidel N; Fellermeier S; Messerschmidt SK; Richter F; Kontermann RE
Protein Eng Des Sel; 2012 Oct; 25(10):603-12. PubMed ID: 22988132
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.
Chesebro B; Britt W; Evans L; Wehrly K; Nishio J; Cloyd M
Virology; 1983 May; 127(1):134-48. PubMed ID: 6305011
[TBL] [Abstract][Full Text] [Related]
15. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
[TBL] [Abstract][Full Text] [Related]
16. Expression, Purification, and Characterization of Anti-
Mwale PF; Lee CH; Lin LT; Leu SJ; Huang YJ; Chiang LC; Mao YC; Yang YY
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940993
[No Abstract] [Full Text] [Related]
17. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
[TBL] [Abstract][Full Text] [Related]
18. Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells.
Zhao Q; Pang J; Yan F; Jiang Y; Cui D; Liu J; Jing L; Li Y; Liu Z; Tao L; Zhao X; Diao A
Protein Expr Purif; 2021 Feb; 178():105783. PubMed ID: 33122138
[TBL] [Abstract][Full Text] [Related]
19. A modular IgG-scFv bispecific antibody topology.
Orcutt KD; Ackerman ME; Cieslewicz M; Quiroz E; Slusarczyk AL; Frangioni JV; Wittrup KD
Protein Eng Des Sel; 2010 Apr; 23(4):221-8. PubMed ID: 20019028
[TBL] [Abstract][Full Text] [Related]
20. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli.
Babaei A; Zarkesh-Esfahani SH; Gharagozloo M
J Microbiol Biotechnol; 2011 May; 21(5):529-35. PubMed ID: 21617352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
